Highlights - Page 2
New french article about phagotherapy - 27/05/2014
The journal pharmaceutiques published in April 2014 an article about new ways to fight against multidrug-resistant bacteria.
Among others, the article talks about phage therapy and Jérôme Gabard, Pherecydes Pharma CEO, is interviewed.
New articles - 13/01/2014
Two new french articles were published in January 2014 on Phage therapy.
Le Monde and Le Progres (French newspapers) published articles on phage therapy and the Phagoburn project.
Pherecydes Pharma at the European Parliament - 17/09/2013
Dr. Jérôme Gabard (Pherecydes Pharma) took part in a meeting on phage therapy in Brussels on September 17th.
Dr. Jérôme Gabard (Pherecydes Pharma) took part in a meeting on phage therapy organized by the European Deputy Michèle Rivasi (The Greens/European Free Alliance) in Brussels on September 17th, in association with Maryvonne Blondin Senator (PS).
This meeting gathered Dr. Alain Dublanchet, Olivier Patey (Villeneuve Saint Georges Hospital), Patrick Jault (Percy Hospital), Jean-Paul Pirnay and Gilbert Verbeken (Queen Astrid Hospital) key phage therapy actors, looking forward a regulatory proposal in this medical area.
Among others, Dominique Rivasi (General Director of the European Joint Research Center), Guy Van Den Eede(Adviser for BioEconomy of the JRC), Marco Cavaleri (Head of Anti-infectives and Vaccines, European Medicines Agency), Dominique Labbé (Associate Director of Innovative Therapies, Human Derived and Vaccines Direction of the French National Agency for Medicines and Health Products Safety), as well as, Laurent Bretaudeau (Clean Cells) were actively involved in the meeting.
Pherecydes Pharma Present PHAGOBURN at Evergreen - 01/08/2013
The 20th Biennial Evergreen International Phage Meeting will take place at Evergreen (Olympia, WA, USA), from Aug. 4-9, 2013.
Dr. Jérôme Gabard will introduce the project PHAGOBURN: first european clinical study on phage therapy to treat E. coli and P. aeruginosa skin infections in burn wounds. A project supported by the European Union FP7.
Pherecydes Pharma secures DGA funding for evaluating the use of bacteriophages on infected burns. - 18/01/2012
The French Government Defence procurement agency invests €900,000 towards Pherecydes Pharma managed €1.2-million project, involving several university and military laboratories.
The full text of the press release is available by clicking on the following link.
Internet media coverage resulting from the announcement is available hereunder:
"Tough Microbe Infections" Forum - January 2012 - 11/01/2012
Pherecydes Pharma is attending the Forum coorganised by PHAG ESPOIRS and LE LIEN associations, as well as their partners, Narbonne Hospital and City, on January 25, 2012 in Narbonne - France, at 9h15, in Le Théatre.
Doctor Jérôme Larché, Président of PHAG ESPOIRS Association, has invited several patient associations and clinicians to discuss about antibiotic resistance and bacteriophage based treatments. The program of this free forum, open to the public, is dowloadable by clicking on the following link.